Diabetes Medicine Franchise in Ahmedabad

Anti-diabetic Tablet Supplier in Mumbai

Type 2 Diabetes Medicine Distributor in Delhi

Oral Hypoglycemic Tablet Manufacturer in Bangalore

Diabetes Care Tablet Stockist in Hyderabad
Diabetology Medicine Exporter in Chandigarh

Home/Products /dapagliflozin-10mg-metformin-500mg-sr-vildagliptin-100mg-tablets

Dapoflit VM Tablet

Composition : Dapagliflozin (10mg) + Metformin (500mg) + Vildagliptin (100mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Dapagliflozin 10mg + Metformin 500mg SR + Vildagliptin 100mg Tablet is a triple-combination oral anti-diabetic formulation used for the treatment of type 2 diabetes mellitus in patients requiring improved glycemic control.

This combination works through complementary mechanisms—dapagliflozin reduces glucose reabsorption via the kidneys, metformin improves insulin sensitivity and reduces hepatic glucose production, while vildagliptin enhances incretin activity to regulate insulin secretion.

Clinically, it is prescribed for patients with uncontrolled blood glucose levels, helping manage fasting and postprandial glucose while reducing the risk of long-term diabetic complications.

With rising diabetes prevalence and strong demand for fixed-dose combinations, this formulation supports consistent prescriptions, enhances portfolio strength, and helps attract long-term associations through effective, comprehensive glucose management solutions.

Read More

About the Product

Dapagliflozin 10mg + Metformin 500mg SR + Vildagliptin 100mg Tablet is a triple-combination oral anti-diabetic formulation used for the treatment of type 2 diabetes mellitus in patients requiring improved glycemic control.

This combination works through complementary mechanisms—dapagliflozin reduces glucose reabsorption via the kidneys, metformin improves insulin sensitivity and reduces hepatic glucose production, while vildagliptin enhances incretin activity to regulate insulin secretion.

Clinically, it is prescribed for patients with uncontrolled blood glucose levels, helping manage fasting and postprandial glucose while reducing the risk of long-term diabetic complications.

With rising diabetes prevalence and strong demand for fixed-dose combinations, this formulation supports consistent prescriptions, enhances portfolio strength, and helps attract long-term associations through effective, comprehensive glucose management solutions.

Common side effects may include nausea, diarrhea, abdominal discomfort, headache, urinary tract infections, or genital infections. Rarely, hypoglycemia may occur when used with other antidiabetic agents.

Dapoflit VM Tablet is indicated for the management of type 2 diabetes mellitus in patients whose blood glucose levels are not adequately controlled with diet and exercise alone. It helps achieve better fasting and postprandial glycemic control as advised by a physician.

Use this medicine strictly under medical supervision. Follow the prescribed dosage and timing. Monitor blood glucose levels regularly. Caution is advised in patients with renal impairment, dehydration, or a history of recurrent infections.

Store below 25°C in a cool, dry place. Protect from moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation